Filing Details
- Accession Number:
- 0001209191-21-017572
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-03 21:05:17
- Reporting Period:
- 2021-03-01
- Accepted Time:
- 2021-03-03 21:05:17
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1533040 | Phio Pharmaceuticals Corp. | PHIO | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1792987 | L Robert Ferrara | C/O Phio Pharmaceuticals Corp. 257 Simarano Drive, Suite 101 Marlborough MA 01752 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.0001 Par Value | Acquisiton | 2021-03-01 | 10,000 | $0.00 | 12,318 | No | 4 | A | Direct | |
Common Stock, $0.0001 Par Value | Acquisiton | 2021-03-03 | 682 | $3.15 | 13,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | P | Direct |
Footnotes
- Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date.
- Effective as of 12:01 a.m. Eastern Time on January 15, 2020, the issuer effected a reverse split of its outstanding shares of common stock at a ratio of 1-for-55.